Ades, L., Guerci-Bresler, A., Cony-Makhoul, P., Legros, L., Sebert, M., Braun, T., Delaunay, J., Desseaux, K., Chevret, S. and Fenaux, P. (2019) “A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM)”, Haematologica. Pavia, Italy, 104(4), pp. e131-e133. doi: 10.3324/haematol.2018.203885.